Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Clinical trial NCT07701161 · RECRUITING
Trial details
- NCT number
- NCT07701161
- Sponsor
- Neurogen Biomarking LLC
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-13
- Primary completion
- 2026-03-20
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.